Pharma & Healthcare

Open Options’ unique process and proprietary game theory software has helped guide senior executives in pharmaceuticals, medical devices and health care for decades. The magnitude and uncertainty associated with the decisions to be made, combined with strong regulatory oversight and the interplay of many important stakeholders in healthcare, makes the Open Options process ideally suited for helping organizations in these industries deal with their toughest challenges. The neutral nature of the process allows pharma and healthcare organizations to realize their optimal, unbiased strategy and ensures no strategic pathway is left unconsidered. We have worked with many of the leading branded pharmaceutical and medical device companies around the globe, on projects as large as “what does the future of healthcare look like in the US market” to as granular as “how do we win a tender Denmark.”


The Open Options process is ideally suited for:

• Market entry and product launches
• Strategic pricing strategies and price-war avoidance
• Broader market access strategy optimization
• Navigating losses of exclusivity/patents
• Contract negotiations - Payers, Regulators, Insurance
• Tender submission optimization
• Behavioral analysis of HCPs, Advocacy and/or Patient groups
• Defense against new market entrants
• Supply chain optimization
• Corporate Social Responsibility Issues
• Strategic Alliances
• Mergers and Acquisitions
• Adoption/Acquisition of new technologies
• Any other complex multistakeholder issue...

The best way to predict the future is to create it.

If your organization is facing a complex opportunity or challenge with a high degree of uncertainty and involving multiple external stakeholders, we can help to determine your Best Attainable Outcome and the path to reach it.